“高收益+低回撤”榜单来袭！百亿主动权益基金经理冠军赚近70%！中欧葛兰进入10强

Core Viewpoint - The A-share market has shown a "slow bull" trend in the first three quarters of this year, with significant contributions from the TMT (Technology, Media, and Telecommunications) sector, particularly in AI, robotics, and semiconductors. Active equity fund managers who actively position in new directions have performed well, but the volatility in popular sectors and events like the "tariff shock" in early April have impacted their ability to manage drawdowns, affecting investor experiences [4]. Summary by Category Overall Performance of Active Equity Fund Managers - In the first three quarters of this year, there are 1,698 active equity fund managers with an average return of 34.08% and a median return of 30.45%. The average drawdown is -13.93%, with a median of -13.05% [4][5]. - Fund managers managing over 100 billion yuan have the highest median returns at 36.79%, but also face larger drawdowns [5]. Performance by Management Scale - Over 100 Billion Yuan: 80 managers, median return 36.79%, median drawdown -14.13%. Top performers include Zhang Wei from Huatai-PineBridge and Ge Lan from China Europe Fund, both heavily invested in the pharmaceutical sector [6][7]. - 50-100 Billion Yuan: 130 managers, median return 35.28%, median drawdown -13.28%. Top performers include Zheng Ning from Zhongyin Fund, with a return of 95.01% [9][10]. - 20-50 Billion Yuan: 275 managers, median return 32.82%, median drawdown -13.08%. Top performers include Dan Lin from Yongying Fund, with a return of 97.40% [13][14]. - Below 20 Billion Yuan: 1,213 managers, median return 29.46%, median drawdown -12.95%. Top performers include Wang Chao from Fortune Fund, with a return of 93.31% [16]. Notable Fund Managers - Zhang Wei: Achieved a return of 69.62% with a maximum drawdown of -10.01%, managing six funds [7][8]. - Zheng Ning: Focused on innovative drugs, achieving a return of 95.01% with a maximum drawdown of -13.06% [10][12]. - Dan Lin: Achieved a return of 97.40% with a maximum drawdown of -12.88% [14]. - Zhao Longlong: Managed to achieve a return of 62.08% with the smallest drawdown of -9.51% among his peers [15]. Investment Focus - Fund managers are increasingly focusing on sectors such as innovative pharmaceuticals and high-end medical devices, with a notable emphasis on the potential of Chinese innovative drugs in international markets [8][10].